The high-profile stockpicker is the eye disorder treatment hopeful’s biggest shareholder. Ahead of the results of a crucial clinical trial, shorts are rising.
The increasing exposure of the biggest retirement savings investors to US sharemarkets has driven the biggest fall in the value of their assets in nine months.
The 139-year-old group had proposed the sale to the private equity giant more than a year ago. It will now try to sell the wealth management unit separately.
The Reserve Bank cut the cash rate, but the extent to which it tempered enthusiasm for more reductions brings into question why the board chose to move at all.
The financial market has predictive powers that should be respected. But there may be hidden factors influencing the odds of an RBA rate cut this week.